Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Willem Adriaan de Jongh"'
Autor:
Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn, Vladislav Soroka, Sebenzile K. Myeni, Robert Dagil, Christoph M. Janitzek, Max Søgaard, Kara-Lee Aves, Emma W. Horsted, Sayit Mahmut Erdoğan, Tobias Gustavsson, Jerzy Dorosz, Stine Clemmensen, Laurits Fredsgaard, Susan Thrane, Elena E. Vidal-Calvo, Paul Khalifé, Thomas M. Hulen, Swati Choudhary, Michael Theisen, Susheel K. Singh, Asier Garcia-Senosiain, Linda Van Oosten, Gorben Pijlman, Bettina Hierzberger, Tanja Domeyer, Blanka W. Nalewajek, Anette Strøbæk, Magdalena Skrzypczak, Laura F. Andersson, Søren Buus, Anette Stryhn Buus, Jan Pravsgaard Christensen, Tim J. Dalebout, Kasper Iversen, Lene H. Harritshøj, Benjamin Mordmüller, Henrik Ullum, Line S. Reinert, Willem Adriaan de Jongh, Marjolein Kikkert, Søren R. Paludan, Thor G. Theander, Morten A. Nielsen, Ali Salanti, Adam F. Sander
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Here the authors generate a capsid-like particle based vaccine candidate displaying the receptor-binding domain of the SARS-CoV-2 spike protein and show induction of neutralizing antibodies after intramuscular prime-boost immunization in mice.
Externí odkaz:
https://doaj.org/article/c047e4469bfc4df49317bf7ddb5a7a95
Autor:
Linda van Oosten, Jort J. Altenburg, Cyrielle Fougeroux, Corinne Geertsema, Fred van den End, Wendy A. C. Evers, Adrie H. Westphal, Simon Lindhoud, Willy van den Berg, Daan C. Swarts, Laurens Deurhof, Andreas Suhrbier, Thuy T. Le, Shessy Torres Morales, Sebenzile K. Myeni, Marjolein Kikkert, Adam F. Sander, Willem Adriaan de Jongh, Robert Dagil, Morten A. Nielsen, Ali Salanti, Max Søgaard, Timo M. P. Keijzer, Dolf Weijers, Michel H. M. Eppink, René H. Wijffels, Monique M. van Oers, Dirk E. Martens, Gorben P. Pijlman
Publikováno v:
mBio, Vol 12, Iss 5 (2021)
Vaccines pave the way out of the SARS-CoV-2 pandemic. We have developed a virus-like particle (VLP)-based vaccine using the baculovirus-insect cell expression system, a robust production platform known for its scalability, low cost, and safety. Bacul
Externí odkaz:
https://doaj.org/article/9d799f0e15554e7aafc11f877069c7c0
Autor:
Louise Goksøyr, Anders B. Funch, Anna K. Okholm, Thor G. Theander, Willem Adriaan de Jongh, Charlotte M. Bonefeld, Adam F. Sander
Publikováno v:
Vaccines, Vol 10, Iss 5, p 828 (2022)
Hypersensitivity to a contact allergen is one of the most abundant forms of inflammatory skin disease. Today, more than 20% of the general population are sensitized to one or more contact allergens, making this disease an important healthcare issue,
Externí odkaz:
https://doaj.org/article/a2766cc86870421dba1c748be170f7a7
Autor:
Arianna Palladini, Susan Thrane, Christoph M. Janitzek, Jessica Pihl, Stine B. Clemmensen, Willem Adriaan de Jongh, Thomas M. Clausen, Giordano Nicoletti, Lorena Landuzzi, Manuel L. Penichet, Tania Balboni, Marianna L. Ianzano, Veronica Giusti, Thor G. Theander, Morten A. Nielsen, Ali Salanti, Pier-Luigi Lollini, Patrizia Nanni, Adam F. Sander
Publikováno v:
OncoImmunology, Vol 7, Iss 3 (2018)
Overexpression of human epidermal growth factor receptor-2 (HER2) occurs in 20–30% of invasive breast cancers. Monoclonal antibody therapy is effective in treating HER2-driven mammary carcinomas, but its utility is limited by high costs, side effec
Externí odkaz:
https://doaj.org/article/e1b993a0c5c5445cb0c1372cb80b222f
Autor:
Linda van Oosten, Kexin Yan, Daniel J. Rawle, Thuy T. Le, Jort J. Altenburg, Cyrielle Fougeroux, Louise Goksøyr, Willem Adriaan de Jongh, Morten A. Nielsen, Adam F. Sander, Gorben P. Pijlman, Andreas Suhrbier
Publikováno v:
van Oosten, L, Yan, K, Rawle, D J, Le, T T, Altenburg, J J, Fougeroux, C, Goksøyr, L, de Jongh, W A, Nielsen, M A, Sander, A F, Pijlman, G P & Suhrbier, A 2022, ' An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice ', Journal of Virology, vol. 96, no. 14, 00844-22 . https://doi.org/10.1128/jvi.00844-22
Journal of Virology 96 (2022) 14
Journal of Virology
Journal of Virology, 96(14)
Journal of Virology 96 (2022) 14
Journal of Virology
Journal of Virology, 96(14)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e75d317a5ed3d6eb2fa9bf46ccced70e
https://curis.ku.dk/ws/files/317092972/jvi.00844_22.pdf
https://curis.ku.dk/ws/files/317092972/jvi.00844_22.pdf
Autor:
Cyrielle Fougeoux, Louise Goksøyr, Manja Idorn, Vladislav Soroka, Sebenzile K. Myeni, Robert Dagil, Christoph M. Janitzek, Teit Søgaard, Kara-Lee Aves, Emma W. Horsted, Sayit Mahmut Erdoğan, Tobias Gustavsson, Jerzy Dorosz, Stine Clemmensen, Laurits Larsen, Susan Thrane, Elena E. Vidal-Calvo, Paul Khalifé, Thomas M. Hulen, Swati Choudhary, Michael Theisen, Susheel Singh, Asier Garcia-Senosiain, Linda Van Oosten, Gorben Pijlman, Bettina Hierzberger, Tanja Domeyer, Blanka W. Nalewajek, Anette Strøbæk, Magdalena Skrzypczak, Laura F. Andersson, Tim Dalebout, Kasper Iversen, Lene H. Harritshøj, Benjamin Mordmüller, Henrik Ullum, Line Reinert, Willem Adriaan de Jongh, Marjolein Kikkert, Soren Paludan, Thor Theander, Morten Nielsen, Ali Salanti, Adam Sander
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we developed two capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. RBD antigens were displayed on AP205 CL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fa692aa0e0459551e3a1c2cc1dc4e00
https://doi.org/10.21203/rs.3.rs-45062/v1
https://doi.org/10.21203/rs.3.rs-45062/v1